List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 3123 studies with search of: "Breast Neoplasms"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Capecitabine in Women With Operable Breast Cancer
Conditions: Invasive Breast Carcinoma;   Primary Invasive Breast Cancer;   Stage I Breast Cancer;   Stage II Breast Cancer;   Stage III Breast Cancer
Intervention: Drug: Capecitabine
2 Recruiting Vaccine Therapy in Treating Women With Triple-Negative Breast Cancer
Conditions: Breast Cancer;   Inflammatory Breast Cancer;   Stage I Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Triple-negative Breast Cancer
Interventions: Biological: MUC-1 peptide vaccine;   Biological: poly ICLC;   Biological: MUC1 peptide-poly-ICLC adjuvant vaccine;   Other: laboratory biomarker analysis;   Other: enzyme-linked immunosorbent assay;   Other: flow cytometry
3 Completed A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer
Conditions: Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IV Breast Cancer;   Breast Cancer;   Locally Advanced
Intervention: Drug: gemcitabine, epirubicin, paclitaxel
4 Recruiting Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Conditions: Breast Cancer;   Breast Neoplasms;   Breast Tumors;   Cancer;   Locally Recurrent and Metastatic Breast Cancer;   Metastases;   Metastatic Cancer;   Oncology;   Solid Tumors;   Tumors
Interventions: Drug: AMG 386 10 mgkg, Paclitaxel and Trastuzumab;   Drug: AMG 386 3 mg/kg, Paclitaxel and Trastuzumab;   Drug: AMG 386 10 mg/kg, Capecitabine and Lapatinib;   Drug: AMG 386 3 mg/kg, Capecitabine and Lapatinib
5 Recruiting Efficacy and Safety Evaluating IPI-504 With Trastuzumab in Patients With Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer
Conditions: Breast Cancer;   Advanced Breast Cancer;   Metastatic Breast Cancer;   Cancer of the Breast
Intervention: Drug: IPI-504 and Trastuzumab
6 Active, not recruiting A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer
Conditions: Breast Neoplasms;   Breast Tumors;   Breast Cancer;   Locally Recurrent and Metastatic Breast Cancer
Interventions: Drug: AMG 706 placebo;   Drug: Bevacizumab;   Drug: AMG 706
7 Terminated DOXIL® vs. Xeloda® as First Line Chemotherapy for Metastatic Breast Cancer in Women 60 Years and Older
Conditions: Breast Neoplasms;   Cancer of Breast;   Breast Cancer;   Cancer of the Breast
Intervention: Drug: pegylated liposomal doxorubicin hydrochloride (DOXIL®) or capecitabine (Xeloda®)
8 Recruiting Study to Evaluate Exemestane With and Without SNDX-275 in Treatment of Postmenopausal Women With Advanced Breast Cancer
Conditions: Breast Cancer;   Estrogen Receptor-Positive Breast Cancer;   Breast Cancer, Estrogen Receptor-Positive;   ER+ Breast Cancer
Interventions: Drug: SNDX-275;   Drug: exemestane
9 Active, not recruiting Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer
Conditions: Breast Cancer;   Stage I Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer
Interventions: Drug: Cyclophosphamide;   Drug: Epirubicin;   Drug: Capecitabine
10 Active, not recruiting A Trial of Taxol and Bevacizumab vs. Gemcitabine, Taxol, and Bevacizumab in Advanced Breast Cancer
Conditions: Breast Cancer;   Cancer of Breast;   Cancer of the Breast;   Breast Neoplasms
Interventions: Drug: gemcitabine;   Drug: paclitaxel;   Drug: bevacizumab
11 Recruiting Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer
Conditions: Breast Cancer;   Cancer of the Breast;   Breast Neoplasm
Interventions: Other: Letrozole (Femara);   Drug: Letrozole; Avastin
12 Recruiting Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-Line Therapy in HER2/Neu-Positive Breast Cancer
Conditions: Breast Cancer;   Metastatic Breast Cancer;   Advanced Breast Cancer;   HER2/Neu-Positive Breast Cancer
Interventions: Drug: Capecitabine;   Drug: Lapatinib
13 Withdrawn Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer
Conditions: Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: exemestane;   Procedure: adjuvant therapy;   Procedure: aromatase inhibition;   Procedure: conventional surgery;   Procedure: endocrine therapy;   Procedure: hormone therapy;   Procedure: neoadjuvant therapy;   Procedure: surgery
14 Recruiting MPA Revisited: A Phase II Study of Anti-Metastatic, Anti-Angiogenic Therapy in Postmenopausal Patients With Hormone Receptor Negative Breast Cancer. A Translational Breast Cancer Research Consortium (TBCRC) Trial
Conditions: Hormone Receptor Negative Breast Cancer;   Locally Recurrent Breast Cancer;   Metastatic Breast Cancer
Interventions: Drug: Medroxyprogesterone progesterone acetate (MPA);   Drug: Medroxyprogesterone Acetate with Cyclophosphamide plus Methotrexate
15 Recruiting Multipeptide Vaccine for Advanced Breast Cancer
Conditions: Breast Neoplasm;   Breast Cancer;   Cancer of the Breast;   Carcinoma, Ductal
Intervention: Biological: hTERT/Survivin Multi-Peptide Vaccine
16 Active, not recruiting Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer
Conditions: Depression;   Stage I Breast Cancer;   Stage IIIA Breast Cancer;   Nutrition;   Stage II Breast Cancer;   Psychosocial Effects/Treatment;   Quality of Life
Intervention:
17 Completed A Phase III Trial For Patients With Metastatic Breast Cancer
Conditions: Breast Cancer;   Breast Neoplasms;   Cancer of the Breast
Interventions: Drug: gemcitabine;   Drug: docetaxel;   Drug: capecitabine
18 Completed A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease
Conditions: Breast Neoplasms;   Cancer of the Breast;   Breast Cancer
Interventions: Drug: Gemcitabine;   Drug: Trastuzumab
19 Active, not recruiting Preoperative Herceptin and Navelbine for Breast Cancer
Conditions: Breast Cancer;   Stage II Breast Cancer;   Stage III Breast Cancer
Interventions: Drug: Herceptin;   Drug: Navelbine;   Drug: Doxorubicin;   Drug: Cyclophosphamide;   Drug: Paclitaxel
20 Active, not recruiting Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer
Conditions: Breast Cancer;   Triple Negative Breast Cancer;   Metastatic Breast Cancer
Interventions: Drug: AZD2281;   Drug: Paclitaxel

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services